SCHEMBL21298045

SCHEMBL21298045

c1ccc2cc3c(cc2c1)c1c2ccccc2c2ccccc2c1n1c2ccc(-c4ccc5cc6c(cc5c4)c4c5ccccc5ccc4n4c5ccccc5nc64)cc2nc31

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.38
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 5/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
FLT3 P36888 3/20 0.37
MAPT P10636 7/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 3/20 0.34
BMX P51813 2/20 0.34
BCL2 P10415 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CASP1 P29466 1/20 0.32
CYP2C19 P33261 1/20 0.32
CASP7 P55210 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959762 0.85 KDM4E (0.48) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL21790995 0.84 KDM4E (0.49) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL21790959 0.80 KDM4E (0.33) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL10023549 0.79 HPGD (0.43) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL19959755 0.79 KDM4E (0.51) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL21790958 0.77 PRF1 (0.36) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL10023445 0.76 HPGD (0.42) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL10023790 0.76 HPGD (0.42) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL22414084 0.75 HPGD (0.48) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL10023498 0.75 HPGD (0.48) HPGDKDM4EALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392387-B2 Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392387-B2 Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials NT5C, HTR3D, IK HPGD 1744/4885KDM4E 2046/4885ALDH1A1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.